These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [A randomized controlled study of adjuvant immunotherapy with N-CWS for head and neck malignancies]. Author: Sakai S, Itoh M, Matsunaga T, Yoshida J, Sato T, Miyahara Y, Matsunaga T, Hyoh Y, Ohyama K, Katsuta K. Journal: Gan No Rinsho; 1985 Sep; 31(11):1353-61. PubMed ID: 4068237. Abstract: The nonspecific adjuvant immunotherapeutic effectiveness of the cell wall skeleton of Nocardia rubra (N-CWS) was studied in patients with head-and-neck malignancies. This study involved 390 patients seen from March 1980 to July 1982. The patients qualifying for statistical analysis were limited to 276 with squamous cell carcinoma without a vestige of tumor after four months of radical therapy. They were divided into two background-factors matched groups of 132 immunotherapy and 144 control patients. The overall two-year nonrecurrence rate was 70.4% for the immunotherapy group and 67.1% for the control. This difference, however, was amplified, when the patients' stages were limited to III and IV: 66.6% for the immunotherapy group and 55.3% for the control.[Abstract] [Full Text] [Related] [New Search]